Integra LifeSciences Holdings Corporation (IART) Financial Statements (2024 and earlier)

Company Profile

Business Address 1100 CAMPUS ROAD
PRINCETON, NJ 08540
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

3/31/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments309457513470199139
Cash and cash equivalents276457513470199139
Short-term investments33     
Receivables259263232226275266
Inventory, net of allowances, customer advances and progress billings390325317310316280
Inventory390325317310316280
Prepaid expense67     
Disposal group, including discontinued operation    162  
Other current assets33     
Other undisclosed current assets  11791696890
Total current assets:1,0581,1611,1541,237858775
Noncurrent Assets
Operating lease, right-of-use asset156148858495
Property, plant and equipment340311312288337300
Intangible assets, net (including goodwill)2,1232,1652,1591,9221,9862,006
Goodwill1,0551,0391,013932954926
Intangible assets, net (excluding goodwill)1,0681,1271,1469891,0321,079
Deferred income tax assets4646577413
Other noncurrent assets585716111520
Other undisclosed noncurrent assets      7
Total noncurrent assets:2,7242,7282,6292,3782,4452,333
TOTAL ASSETS:3,7823,8903,7823,6153,3033,108
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities193182275225269236
Employee-related liabilities93767976
Accounts payable92102625511376
Accrued liabilities10180120947785
Deferred revenue97555
Debt153845345723
Restructuring reserve   10   
Disposal group, including discontinued operation    12  
Contract with customer, liability4
Other undisclosed current liabilities91935125  
Total current liabilities:307321340401331263
Noncurrent Liabilities
Long-term debt and lease obligation1,3961,3001,4791,4961,2961,211
Long-term debt, excluding current maturities1,3961,3001,3891,4081,1991,211
Liabilities, other than long-term debt41036817320316289
Deferred revenue897 7
Contract with customer, liability9
Deferred income tax liabilities3563461637
Other liabilities20013912018711880
Operating lease, liability167157908898
Other undisclosed noncurrent liabilities8296106 97170
Total noncurrent liabilities:1,8871,7641,7581,6991,5551,470
Total liabilities:2,1942,0852,0982,1001,8871,732
Equity
Equity, attributable to parent1,5881,8041,6851,5151,4171,376
Common stock111111
Treasury stock, value(647)(363)(234)(235)(120)(121)
Additional paid in capital1,3021,2771,2651,2911,2141,193
Accumulated other comprehensive income (loss)(15)10(45)(74)(76)(45)
Retained earnings947879699532399348
Total equity:1,5881,8041,6851,5151,4171,376
TOTAL LIABILITIES AND EQUITY:3,7823,8903,7823,6153,3033,108

Income Statement (P&L) ($ in millions)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues1,5421,5581,5421,3721,5181,472
Cost of revenue
(Cost of Goods and Services Sold)
(657)(587)(598)(521)(565)(571)
Gross profit:885970945851953901
Operating expenses(773)(731)(747)(700)(859)(790)
Operating income:11223919715194111
Nonoperating income212426142011
Investment income, nonoperating171279113
Other nonoperating income412194108
Interest and debt expense(51)(50)(50)(72)(54)(65)
Income from continuing operations before equity method investments, income taxes:81213173946057
Other undisclosed income from continuing operations before income taxes  142   
Income from continuing operations before income taxes:81214215946057
Income tax expense (benefit)(13)(33)(46)40(10)3
Income from continuing operations:681811691345061
Income before gain (loss) on sale of properties:1691345061
Net income available to common stockholders, diluted:681811691345061

Comprehensive Income ($ in millions)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net income:681811691345061
Other comprehensive income (loss) 4(12)(5)21(2)(22)
Other undisclosed comprehensive income      
Comprehensive income:721681641554839
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(29)6834(19)(29) 
Comprehensive income, net of tax, attributable to parent:422361981361939

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: